ALVO

Alvontech (ALVO)

Alvontech

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALVO

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	21:00	GlobeNewswire Inc.	Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)	NASDAQ:ALVO	Alvontech
2024/05/02	20:15	GlobeNewswire Inc.	Alvotech Announces Participation at BofA Securities Healthcare Conference 2024	NASDAQ:ALVO	Alvontech
2024/04/30	17:00	Business Wire	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)	NASDAQ:ALVO	Alvontech
2024/04/30	17:00	GlobeNewswire Inc.	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)	NASDAQ:ALVO	Alvontech
2024/04/24	17:00	GlobeNewswire Inc.	Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)	NASDAQ:ALVO	Alvontech
2024/04/19	19:10	GlobeNewswire Inc.	Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)	NASDAQ:ALVO	Alvontech
2024/04/17	06:43	Business Wire	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2024/04/17	06:30	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2024/04/03	20:41	GlobeNewswire Inc.	Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024	NASDAQ:ALVO	Alvontech
2024/03/23	05:15	GlobeNewswire Inc.	Alvotech Announces Increase in Number of Own Shares	NASDAQ:ALVO	Alvontech
2024/03/21	05:15	GlobeNewswire Inc.	Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update	NASDAQ:ALVO	Alvontech
2024/03/20	20:17	IH Market News	U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip	NASDAQ:ALVO	Alvontech
2024/03/06	06:00	GlobeNewswire Inc.	Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2024/03/01	06:05	GlobeNewswire Inc.	Alvotech Appoints Interim Chief Quality Officer	NASDAQ:ALVO	Alvontech
2024/02/26	18:25	GlobeNewswire Inc.	Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share	NASDAQ:ALVO	Alvontech
2024/02/24	10:15	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®	NASDAQ:ALVO	Alvontech
2024/02/24	10:15	Business Wire	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®	NASDAQ:ALVO	Alvontech
2024/02/15	20:30	GlobeNewswire Inc.	Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2024/01/29	18:00	GlobeNewswire Inc.	Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
2024/01/20	02:31	Dow Jones News	Alvotech Shares Climb After FDA Concludes Facility Inspection	NASDAQ:ALVO	Alvontech
2024/01/20	01:30	GlobeNewswire Inc.	Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04	NASDAQ:ALVO	Alvontech
2024/01/10	17:30	GlobeNewswire Inc.	STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara	NASDAQ:ALVO	Alvontech
2024/01/03	17:30	GlobeNewswire Inc.	Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)	NASDAQ:ALVO	Alvontech
2023/11/29	18:00	GlobeNewswire Inc.	Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®	NASDAQ:ALVO	Alvontech
2023/11/29	06:15	GlobeNewswire Inc.	Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update	NASDAQ:ALVO	Alvontech
2023/11/21	22:00	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2023/11/14	21:00	GlobeNewswire Inc.	Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki™ (AVT04), the First Biosimilar of Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2023/11/10	23:30	GlobeNewswire Inc.	STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara	NASDAQ:ALVO	Alvontech
2023/11/07	22:00	GlobeNewswire Inc.	Alvotech to Present at the Jefferies 2023 London Healthcare Conference	NASDAQ:ALVO	Alvontech
2023/10/12	17:00	GlobeNewswire Inc.	Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04	NASDAQ:ALVO	Alvontech